3:
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP.
Am J Pathol. 2002 Jun;160(6):2207-17.
PMID: 12057923 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
10:
Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells.
Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, Lisanti MP.
Mol Cell Biol. 2002 Jun;22(11):3905-26.
PMID: 11997523 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
13:
Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.
Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP.
J Biol Chem. 2002 Mar 8;277(10):8635-47. Epub 2001 Dec 5.
PMID: 11739396 [PubMed - indexed for MEDLINE]
Related Articles
19:
Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.
Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP.
J Biol Chem. 2002 Oct 11;277(41):38988-97. Epub 2002 Jul 23.
PMID: 12138167 [PubMed - indexed for MEDLINE]
Related Articles